NYXH

Nyxoah SA

Add to Watchlist

Advanced Chart

8.220

-0.06(-0.725%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

8.370

Open

8.370

VWAP

8.19

Vol

11.52K

Mkt Cap

307.65M

Low

8.100

Amount

94.36K

EV/EBITDA(TTM)

Total Shares

34.36M

221.78M

EV/OCF(TTM)

P/S(TTM)

56.19

Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

5.44M

+330.69%

-0.548

+18.44%

2.38M

+87.98%

-0.519

+4.68%

1.33M

+72.89%

-0.569

+33.04%

Estimates Revision

The market is revising Downward the revenue expectations for Nyxoah SA (NYXH) for FY2025, with the revenue forecasts being adjusted by -25.74% over the past three months. During the same period, the stock price has changed by 38.38%.

Revenue Estimates for FY2025

Revise Downward

-25.74%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+5.89%

In Past 3 Month

Stock Price

Go Up

+38.38%

In Past 3 Month

4 Analyst Rating

82.73% Upside

Wall Street analysts forecast NYXH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NYXH is 15.02 USD with a low forecast of 14.00 USD and a high forecast of 17.08 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

0 Hold

0 Sell

Strong Buy

82.73% Upside

Current: 8.220

Low

14.00

Averages

15.02

High

17.08

82.73% Upside

Current: 8.220

Low

14.00

Averages

15.02

High

17.08

Stifel

Jonathan Block

Strong Buy

Maintains

$15 → $14

2025-04-21

Reason

Stifel

Jonathan Block

Price Target

$15 → $14

2025-04-21

Maintains

Strong Buy

Reason

HC Wainwright & Co.

Edward White

Strong Buy

Reiterates

$15

2025-04-08

Reason

HC Wainwright & Co.

Edward White

Price Target

$15

2025-04-08

Reiterates

Strong Buy

Reason

HC Wainwright & Co.

Edward White

Strong Buy

Maintains

$17 → $15

2025-03-26

Reason

HC Wainwright & Co.

Edward White

Price Target

$17 → $15

2025-03-26

Maintains

Strong Buy

Reason

Stifel

Jonathan Block

Strong Buy

Maintains

$16 → $15

2025-03-14

Reason

Stifel

Jonathan Block

Price Target

$16 → $15

2025-03-14

Maintains

Strong Buy

Reason

HC Wainwright & Co.

Edward White

Strong Buy

Reiterates

$17

2024-12-13

Reason

HC Wainwright & Co.

Edward White

Price Target

$17

2024-12-13

Reiterates

Strong Buy

Reason

Cantor Fitzgerald

Ross Osborn

Buy

Reiterates

$16

2024-11-05

Reason

Cantor Fitzgerald

Ross Osborn

Price Target

$16

2024-11-05

Reiterates

Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Nyxoah SA (NYXH.O) is -3.53, compared to its 5-year average forward P/E of -7.54. For a more detailed relative valuation and DCF analysis to assess Nyxoah SA 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-7.54

Current PE

-3.53

Overvalued PE

-0.84

Undervalued PE

-14.23

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-5.56

Current EV/EBITDA

-3.06

Overvalued EV/EBITDA

-0.32

Undervalued EV/EBITDA

-10.81

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

66.58

Current PS

12.20

Overvalued PS

163.39

Undervalued PS

-30.23

Financials

Annual

Quarterly

FY2025Q1

YoY :

-12.86%

1.06M

Total Revenue

FY2025Q1

YoY :

+68.99%

-20.64M

Operating Profit

FY2025Q1

YoY :

+88.01%

-22.38M

Net Income after Tax

FY2025Q1

YoY :

+42.86%

-0.60

EPS - Diluted

FY2025Q1

YoY :

+42.67%

-19.90M

Free Cash Flow

FY2025Q1

YoY :

-1.43%

61.84

Gross Profit Margin - %

FY2025Q1

YoY :

+29.75%

-1.36K

FCF Margin - %

FY2025Q1

YoY :

+115.75%

-2.10K

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

681.7K

Volume

6-9

Months

0.0

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

0.0

Volume

Months

6-9

2.9M

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

NYXH News & Events

Events Timeline

2025-05-14 (ET)

2025-05-14

05:20:58

Nyxoah reports Q1 EPS (EUR 0.60) vs. (EUR 0.42) last year

2025-04-08 (ET)

2025-04-08

05:45:49

Nyxoah anticipates FDA approval for Genio system in Q2

2025-03-26 (ET)

2025-03-26

05:16:06

Nyxoah announces FDA approvable letter for Genio pre-market approval application

News

1.0

06-13Newsfilter

Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025

9.5

06-05Benzinga

Why MongoDB Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket

5.0

05-30Newsfilter

Publication relating to transparency notifications

People Also Watch

Amprius Technologies Inc

BrasilAgro - Companhia Brasileira de Propriedades Agricolas

Pangaea Logistics Solutions Ltd

Logility Supply Chain Solutions Inc

Jumia Technologies AG

Horizon Technology Finance Corp

8.060

USD

-1.47%

FAQ

What is Nyxoah SA (NYXH) stock price today?

The current price of NYXH is 8.22 USD — it has decreased -0.72 % in the last trading day.

NYXH

Market Estimates

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

NYXH News & Events

Events Timeline

News

People Also Watch

FAQ

What is Nyxoah SA (NYXH) stock price today?

What is Nyxoah SA (NYXH)'s business?

What is the price predicton of NYXH Stock?

What is Nyxoah SA (NYXH)'s revenue for the last quarter?

What is Nyxoah SA (NYXH)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Nyxoah SA (NYXH)'s fundamentals?

How many employees does Nyxoah SA (NYXH). have?

What is Nyxoah SA (NYXH) market cap?